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graphic indices that is reported to follow renal transplantation improves patient survival has not been Although patients with end-stage renal failure have a investigated.
greatly increased risk of cardiovascular disease (CVD) Methods. We studied 67 patients who underwent renal (regardless of the mode of renal replacement therapy transplantation in our unit between 1988 and 1990 and (RRT )), conventional risk factors for CVD are of in whom echocardiography was performed immedilimited prognostic value [1, 2] . Recently, the prognostic ately prior to transplant surgery and 4 months later.
importance of echocardiographic abnormalities, Pre-and post-transplantation echocardiographic paraincluding left ventricular hypertrophy (LVH ), ventrimeters were compared between the 20 patients who cular dilatation and systolic dysfunction have been have since died and surviving patients and a descriptive shown in patients on maintenance dialysis [3] [4] [5] . We survival analysis was performed.
have extended these findings to show that these echoResults. Following transplantation there was no signicardiographic abnormalities are common-and of proficant change in left ventricular mass index (LVMI ) or gnostic significance-immediately prior to renal end diastolic diameter ( EDD). End systolic diameter transplantation [6 ] . Following transplantation, most, ( ESD) improved in 60% of patients (median 3.3 vs but not all, investigators have shown improvement in 3.7 cm; P=0.031) as did fractional shortening in 67% systolic function and reduction in left ventricular mass (0.33 vs 0.29; P=0.001). However, improvement was (LVM ) [7] [8] [9] [10] [11] [12] , often within a few months of surgery. not associated with survival benefits. We also found However, whether improvement in echocardiographic that prior to transplantation, fractional shortening, parameters results in improved patient survival has ESD and EDD were strongly associated with outcome; not been investigated. We therefore studied 67 patients this was no longer the case following transplantation. who underwent echocardiography immediately prior In contrast, LVMI provided a stronger association to renal transplantation at our institution (between with adverse outcome (albeit of limited statistical signi-1988 and 1990) and in whom repeat echocardiography ficance) following transplantation.
was performed a few months following transplant Conclusions. In this Preliminary Report, we conclude surgery. The aims of this study were to determine that echocardiographic parameters are associated with whether echocardiographic parameters associated with adverse outcome in patients receiving renal replacepoor survival (including LVH, ventricular dilatation ment therapy (RRT ). Different echocardiographic and systolic dysfunction) improve following transparameters are associated with adverse outcome before plantation, and whether improvement confers surand after renal transplantation and improvement of vival benefits. pre-transplant abnormalities (e.g. poor LV systolic function) following transplantation does not necessarily confer survival benefits. Whether this is a genuine Methods observation or a reflection of the interpretation of echocardiographic measurements in dialysis patients Patients requires further investigation.
In a prospective study, echocardiography was performed in
Correspondence and offprint requests to: Dr Alan Jardine, Department transplant echocardiographic findings and long-term survival experience of derived measurements of chamber volume and function [6 ] , only chamber diameters are reported from has recently been reported [6 ] . In 67 patients, repeat echocardiography was performed (prospectively, as part of the study) which fractional shortening (FS=( EDD-ESD)/EDD) was calculated as an index of systolic function. (EDD, end 4 months after transplant surgery (median 4, range 3-12 months). The number of follow-up examinations was diastolic diameter; ESD, end systolic diameter.) restricted to 67 for logistical reasons, as there were no data available at the time of this study on which to base either Analysis the numbers or timing of follow-up examinations. Hence, the timing and number of investigations were arbitrary. The The data are presented as median (range) in Table 2 . current analysis included patients who underwent two echo-Differences between dead and surviving patients were anacardiograms, comparing the pre-and post-transplantation lysed by Kruskall-Wallis analysis of variance. Comparisons findings and their association with long-term survival. All between pre-and post-transplant measurements were made patients gave informed consent and the study was approved by Mann-Whitney U test. Differences in proportions were by the local hospital Ethical Committee. The clinical and determined by x2 test. Survival analysis was then performed demographic features of this subset are similar to the main by the method of Kaplan-Meier. In view of the small number study population (Table 1) [6 ], and the overall survival of subjects studied, and the fact that many of the echocardiosimilar to that previously reported at our centre [13] .
graphic measurements are inter-dependent, these survival Of the 67 patients studied, all commenced RRT in adult curves are largely descriptive and the data were not subjected life and three had diabetic nephropathy. Twenty patients to multivariate analysis [6 ] . Comparison of the survival died before June 1999, when the present analysis was curves above and below the median value was by the logperformed.
rank test (Figure 1 ). The SPSS statistics package (SPSS V7.5, SPSS Inc., USA) was used for these analyses [13, 16 ] .
Patient data
Clinical history and examination findings were recorded prior Results to transplantation, and at the time of follow-up echocardiography. One observer (EM ) measured blood pressure with Of the 67 patients studied, 20 have since died during a standard mercury sphygmomanometer. Follow-up data on a median follow-up period of 9.8 years (range 0. M-mode echocardiogram using methodology in use at the Median blood pressure prior to transplantation was time of the study. The reproducibility of the pre-transplant 150/90 mmHg and fell to 137/86 mmHg at the time of measurements (inter-and intra-observer variability) has the repeat echocardiography, the fall in both systolic been reported and was not repeated for the post-transplant and diastolic blood pressure being significant (P<0.01; measurement [6 ] . LVM was determined from the formula of Table 2 ). There was a trend for the systolic blood SBP was statistically significant (P=0.03; Table 2 ). Haemoglobin increased predictably following transplantation from a median value of 9.0-12.4 g/dl (P= 0.001). 
Echocardiographic data

Outcome and echocardiographic measures
In view of the small number of patients, and the fact that echocardiographic parameters are inter-related, we limited survival analysis to a simple descriptive level [6 ] . The patients were subdivided by the median value of echocardiographic parameters in a Kaplan-Meier analysis [3,6 ] but were not subjected to multivariate analysis ( Figure 1 ). There were significant differences in the pre-transplantation FS, EDD and ESD curves (P=0.005, 0.008 and <0.001 respectively, log-rank test) but there was no significant influence of LVMI (P=0.130).
The post-transplant analysis revealed a different pattern. There were no significant differences in patient survival in the curves for FS or EDD subdividing the population by the median value of each of these parameters (P=0.446 and 0.996 respectively, log rank test) and ESD achieved only borderline significance (P=0.042). An increased LVMI (P=0.092) showed a trend towards adverse outcome but did not achieve statistical significance.
A simple comparison of echocardiographic parameters between survivors and those who died ( Table 1) shows a similar pattern to the Kaplan-Meier curves. Prior to transplantation, the major differences between patients who died and survivors were in end diastolic and systolic dimensions ( EDD 5.6 vs 5.0 cm, P<0.01; ESD 4.1 vs 3.4 cm, P<0.01; dead vs alive), and systolic function ( FS 0.25 vs 0.32, P=0.02). However, there were no significant differences in any of these parameters following transplantation between survivors and patients who died ( Table 2) . Although a higher LVMI was observed both prior to transplantation and Table 2 . Background data on the current patient group, compared with the pre-transplant population [6 ] of which this is a subset. The data set is complete, with the exception of haemoglobin, SBP and DBP for each of which there were only pre-transplant data on 66 patients. in the follow-up measurement in the patients who died, contributing to an increase in blood pressure but also helping to regress LVH by improving oxygen delivery this was of borderline significance (median 168 vs 131 g/m2; P=0.05) prior to transplantation, compared [18] . In our study, there was no change in LVM despite reduction in blood pressure and improved haemowith the highly significant differences in ESD, EDD and FS. In contrast, LVMI was the only significantly globin. Although we do not have information on intravascular volume, nor on other potential condifferent echocardiographic parameter following transplantation (166 vs 132 g/m2; P=0.04).
founding factors such as spontaneous closure of haemodialysis access, it is probable that a longer One of the aims of the present study was to determine whether improvement in pre-transplant echocardio-interval between transplantation and repeat echocardiography would be required to establish the natural graphic parameters associated with poor outcome, results in a reversal of these prognostic influences. history of LVH in this population. Alternatively, the use of magnetic resonance imaging (MRI ) may provide Overall, LVMI, ESD, EDD and FS improved in 53%, 60%, 51% and 67% of patients respectively. However, a better method for the assessment of cardiac structure and function and independent of intravascular volume a benefit on survival was not seen. In the patients whose LVMI decreased, 34% died, compared with 26% [4, 19] permitting a definitive analysis in a small group of patients. in the group whose LVMI increased. The corresponding values for ESD, EDD and FS were 34%, 35% and Correction of intravascular volume homeostasis would be expected to reduce ESD and EDD. 35% in those whose measurements improved and 20%, 24% and 19% in those whose measurements worsened. Surprisingly, only ESD was reduced, a change that is likely to reflect improved systolic function (FS ) in Similarly, the data in Table 2 shows that there were only significant differences in these echocardiographic some patients. The failure of EDD to improve may reflect some irreversible condition, such as dilated parameters (between survivors and those patients who have died) prior to transplantation.
cardiomyopathy, as has previously been described by Parfrey and colleagues [4, 5, 7] . Again, the balance of evidence from published studies is for a major improveDiscussion ment in systolic function following renal transplantation, associated with reduction in intravascular volume and cardiac chamber diameters. Improved FS is likely In a recent study we found that echocardiographic abnormalities present immediately prior to renal trans-to be a consequence of correction of anaemia and uraemia [7, 18] . Thus overall, with the exception of plantation (specifically increased chamber diameter, increased LVMI and reduced FS ) were associated with LVMI, most of the echocardiographic parameters measured in this study showed a trend towards adverse outcome [6 ] . In this study, we have followed a smaller group of patients in whom echocardiography improvement consistent with previous reports [7] [8] [9] [10] [11] [12] .
To determine whether such changes confer survival was performed before and a few months after renal transplantation, and have examined the influence of benefits we compared variables between survivors and patients who died in a limited survival analysis pre-and post-transplantation parameters and changes therein on patient survival. Although previous studies ( Figure 1 ; Table 2 ).
There were differences in the relationship between have reported changes in echocardiographic parameters following transplantation [7-12] we believe this pre-and post-transplant echocardiographic parameters and outcome. Prior to transplantation, ventricular is the first study that attempts to relate these to patient outcome.
dilatation ( ESD and EDD) and poor systolic function were associated with a poor outcome. Pre-transplant LVMI did not change significantly following transplantation. Although the time interval between studies LVMI was also higher in the patients who died (168 vs 131 g/m2) but achieved only borderline significance was short, regression of LVH may occur over such a period in patients with essential hypertension and good (P=0.05). This confirms our previous findings in a larger and related study [6 ] and the findings reported blood pressure control and has previously been observed following renal transplantation [10] . Most for patients on dialysis programmes [1, [3] [4] [5] . However, following transplantation we observed a different relaother studies showing a reduction in LVMI following renal transplantation have been conducted in smaller tionship between echocardiographic parameters and outcome. There was a slightly stronger relationship cohorts of patients but at a longer interval following renal transplantation [7] [8] [9] [10] [11] [12] ; and reduction in LVMI between increased LVMI, which was significantly increased in patients who died (166 vs 132 g/m2; P= has not been a universal observation [11] . Such variability may be due to the balance of determinants of 0.04), but with a clearer pattern in the Kaplan-Meier curves ( Figure 1 ; Table 2 ). In contrast to the preblood pressure following successful transplantation, although it may reflect the variability of echocardio-transplantation findings, chamber diameters and systolic function post-transplantation showed almost no graphic measurements of LVM in dialysis patients [6 ] . While some factors such as intravascular volume association with outcome ( Figure 1 ; Table 2 ). These observations reinforce the prognostic importance of should return to normal, others including immunosuppressive therapy and correction of anaemia, may echocardiographic measurement and show that different parameters are likely to be important at different contribute to a rise in blood pressure and thus increased LVMI. Correction of anaemia may have dual effects, stages in the lives of patients on renal replacement
